The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-fluoro-4-(4-(2-(1H-imidazol-1-yl)ethyl)piperazin-1-yl)-pyrrolo[1,2-a]quinoxaline ID: ALA576046
PubChem CID: 44542078
Max Phase: Preclinical
Molecular Formula: C20H21FN6
Molecular Weight: 364.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccc2c(c1)nc(N1CCN(CCn3ccnc3)CC1)c1cccn12
Standard InChI: InChI=1S/C20H21FN6/c21-16-3-4-18-17(14-16)23-20(19-2-1-6-27(18)19)26-12-10-24(11-13-26)8-9-25-7-5-22-15-25/h1-7,14-15H,8-13H2
Standard InChI Key: ASQVLAWCAVGHRV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
1.8518 -17.5575 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8676 -18.3782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6550 -18.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1282 -17.9458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6332 -17.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5773 -13.8524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5784 -14.6784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8648 -15.0906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8666 -13.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1524 -13.8487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1490 -14.6805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4309 -15.0911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7117 -14.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4378 -13.4276 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7147 -13.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0944 -13.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4343 -12.5234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2645 -12.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9975 -15.0847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9985 -15.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2882 -16.3229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4265 -15.9128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4265 -15.0882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2882 -14.6736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1392 -16.3256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2921 -15.0897 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.1381 -17.1492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
13 15 1 0
14 15 1 0
6 7 2 0
2 3 2 0
7 8 1 0
8 11 2 0
3 4 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 14 1 0
10 9 2 0
13 19 1 0
19 20 1 0
9 6 1 0
10 11 1 0
4 5 2 0
5 1 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
1 2 1 0
22 25 1 0
10 14 1 0
7 26 1 0
11 12 1 0
25 27 1 0
27 1 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.43Molecular Weight (Monoisotopic): 364.1812AlogP: 2.65#Rotatable Bonds: 4Polar Surface Area: 41.60Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.76CX LogP: 2.40CX LogD: 1.88Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -2.08
References 1. Butini S, Budriesi R, Hamon M, Morelli E, Gemma S, Brindisi M, Borrelli G, Novellino E, Fiorini I, Ioan P, Chiarini A, Cagnotto A, Mennini T, Fracasso C, Caccia S, Campiani G.. (2009) Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization., 52 (21): [PMID:19831400 ] [10.1021/jm901126m ]